Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma lines.

Source:http://linkedlifedata.com/resource/pubmed/id/19147758

Clin. Cancer Res. 2009 Jan 15 15 2 532-42

Download in:

View as

General Info

PMID
19147758